Skip to content
Longboard Pharmaceuticals Logo
  • About
    • Overview
  • Our Approach
    • Overview
    • Pipeline
    • GPCR Therapies
    • Publications
  • Patients
    • Advocacy & Research Partners
    • Expanded Access Policy
  • Contact
  • About
    • Overview
  • Our Approach
    • Overview
    • Pipeline
    • GPCR Therapies
    • Publications
  • Patients
    • Advocacy & Research Partners
    • Expanded Access Policy
  • Contact
  • About
    • Overview
  • Our Approach
    • Overview
    • Pipeline
    • GPCR Therapies
    • Publications
  • Patients
    • Advocacy & Research Partners
    • Expanded Access Policy
  • Contact

Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Home ยป Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Juniper Point2023-12-01T00:56:25+00:0011.03.2023|
  • About
  • Our Approach
  • Patients
  • Contact
[email protected]
(858) 789-9283
4275 Executive Square
Suite 950
La Jolla, CA 92037
Privacy Policy Terms of Use
XLinkedIn
Page load link
Go to Top